AMRX Amneal Pharmaceuticals, Inc.

NASDAQ
$19.77

Amneal Pharmaceuticals, Inc. (AMRX) is expected to report earnings on November 6, 2026, before the market open. The consensus earnings estimate is $0.21 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +6.8% since its last earnings release on July 30, 2026.

Amneal Pharmaceuticals Beat Consensus Estimates, Raises Guidance, but Remains In-line with Estimates
Thursday, July 30, 2026 · 6:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 6
Friday · 6:00 AM ET
Earnings Whisper
-
vs $0.21
Rev est $817.01M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $18.21

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc. is a fully-integrated pharmaceutical company focused on the development, manufacturing and distribution of generic and specialty drug products.

Sector

Healthcare

Industry

Drug Manufacturers/Other

Held By 6 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.